Figure 5

Experimental design. C: control (n = 10); D: doxorubicin-treated (n = 10); CT: control-trained (n = 10); DT: doxorubicin-trained (n = 10); AET: aerobic exercise training period; ECO: echocardiographic assessment; ET: maximal exercise test.

Experimental design. C: control (n = 10); D: doxorubicin-treated (n = 10); CT: control-trained (n = 10); DT: doxorubicin-trained (n = 10); AET: aerobic exercise training period; ECO: echocardiographic assessment; ET: maximal exercise test.